Luis E. Rodrı́guez

ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Cherrie K. Donawho, Yan Luo, Yanping Luo et al. · Clinical Cancer Research · 2007 · 762 citations · Full text

Mechanistic Dissection of PARP1 Trapping and the Impact on <i>In Vivo</i> Tolerability and Efficacy of PARP Inhibitors

Todd A. Hopkins, Yan Shi, Luis E. Rodrı́guez et al. · Molecular Cancer Research · 2015 · 257 citations

ABT-888 Confers Broad <i>In vivo</i> Activity in Combination with Temozolomide in Diverse Tumors

Joann P. Palma, Yichun Wang, Luis E. Rodrı́guez et al. · Clinical Cancer Research · 2009 · 138 citations

Identification of Plasmodium falciparum MSP‐1 peptides able to bind to human red blood cells

Mauricio Urquiza, Luis E. Rodrı́guez, Jorge E. Suarez et al. · Parasite Immunology · 1996 · 128 citations

Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents

Yunsong Tong, Jennifer J. Bouska, Eric F. Johnson et al. · Journal of Medicinal Chemistry · 2009 · 108 citations · Full text

Small Molecule Inhibitors, Pharmaceutical Science, Bioorganic Chemistry +18